A critical breakthrough in cancer investigation is arising with the use of nanobodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently disabled in several kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research